Sphingomyelin in Lewy inclusion bodies in Parkinson's disease.
about
Membrane remodeling and mechanics: Experiments and simulations of α-SynucleinPlasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loadingNeuromelanin in the human brain: a review and atlas of pigmented cells in the substantia nigra.Nonselenium glutathione peroxidase in human brain : elevated levels in Parkinson's disease and dementia with lewy bodiesMechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane.The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.The Lewy body in Parkinson's disease and related neurodegenerative disorders.Membrane lipids as therapeutic targets for Parkinson's disease: a possible link between Lewy pathology and membrane lipids.The hypothalamus in Parkinson disease.Idiopathic Parkinson's disease and the Lewy body disorders.Ultrastructure of Lewy bodies in the stellate ganglion.Filaments of Lewy bodies contain insoluble cytoskeletal elementsIncreased norepinephrine-associated adrenomedullary inclusions in Parkinson's disease.Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies.Lewy bodies in parkinsonism share components with intraneuronal protein bodies of normal brains.Purification and characterization of neutral and acid sphingomyelinases from rat brain.Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson's Disease.
P2860
Q28066666-05991573-D689-4BDA-90E7-62EE5429FEE9Q28328341-3DAA2AA1-41C0-4D66-883A-6B1DFFCF8687Q34169019-B076B886-32F2-4CE5-BB93-9FC4976F98C5Q35789018-605EC7E7-B336-4EEF-AC0D-E611DC54DD4EQ36891660-0E37D4BF-6880-402D-9795-2C682E1B81BAQ37003482-54E198AC-7745-4B01-9DA7-444AFD3E8F05Q38012653-7732CFF7-DE30-466F-B9C0-DE41746FEF03Q38648684-EFE1A983-77DF-4287-8971-E27FD2DB98FDQ39463738-59C59021-3075-472C-976B-C2E816F3904AQ39503766-3BF9DADA-18C6-4A14-AFAE-48E72F58A681Q39987734-35B27A68-9EE9-45DE-8059-CEF228ECFB16Q41863606-152343DD-A507-4116-B841-3D92BC47C087Q45294655-96114A10-31C0-411B-AA4F-C6A3188CB974Q48189615-7AE45E71-1879-43F8-9876-18E56D8F6190Q48821685-3C899790-9B9C-4CF1-9E9C-738F4311F464Q52066743-E9016B15-B026-426B-AF95-D5EE325938B4Q52511678-15B6EB0E-5A29-41C3-A91F-C15EF51B5C9EQ55392887-62062AF9-883A-4D7B-B4E4-D32540C71D02Q55412876-76BEE8AB-8FA6-4392-A419-050A344C24A5
P2860
Sphingomyelin in Lewy inclusion bodies in Parkinson's disease.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh-hant
name
Sphingomyelin in Lewy inclusion bodies in Parkinson's disease.
@en
Sphingomyelin in Lewy inclusion bodies in Parkinson's disease.
@nl
type
label
Sphingomyelin in Lewy inclusion bodies in Parkinson's disease.
@en
Sphingomyelin in Lewy inclusion bodies in Parkinson's disease.
@nl
prefLabel
Sphingomyelin in Lewy inclusion bodies in Parkinson's disease.
@en
Sphingomyelin in Lewy inclusion bodies in Parkinson's disease.
@nl
P1433
P1476
Sphingomyelin in Lewy inclusion bodies in Parkinson's disease.
@en
P2093
den Jager WA
P304
P356
10.1001/ARCHNEUR.1969.00480180071006
P577
1969-12-01T00:00:00Z